Hot Sliver Companies To Own For 2015: Sagent Pharmaceuticals Inc.(SGNT)
Sagent Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, sources, and markets pharmaceutical products, principally injectable-based generic equivalents to branded products in the United States. It offers a range of products across anti-infective, oncolytic, and critical care indications in various presentations, including single-and multi-dose vials, pre-filled ready-to-use syringes, and premix bags. The company?s anti-infective products include Levofloxacin, a fluoroquinolone antibacterial for the treatment of various infections caused by susceptible bacteria in adults of age 18 years or older; and Cefepime, an antibiotic used to treat infections of the urinary tract, and skin and skin structure, as well as moderate to severe pneumonia, intra-abdominal infections, and as empiric therapy for febrile neutropenic patients. Its oncology products comprise Gemcitabine, a nucleoside metabolic inhibitor used for the treatment of ovarian, breast, lung, and panc reatic cancers; and Topotecan, a topoisomerase inhibitor for small cell lung cancer sensitive disease. The company also offers critical care products consisting of Adenosine, an antiarrhythmic used for the treatment of cardiac rhythm disturbances; and Heparin, an anticoagulant used to prevent and treat blood clotting during and after surgery and dialysis. As of December 31, 2011, it marketed 33 generic injectable products; and had a new product pipeline that included 36 products represented by 63 Abbreviated New Drug Applications (ANDAs). The company sells its products to pharmaceutical wholesale companies, which then distribute the products to end-user hospitals, long-term care facilities, alternate care sites, and clinics. The company was formerly known as Sagent Holding Co. and changed its name to Sagent Pharmaceuticals, Inc. in April 2011. Sagent Pharmaceuticals, I! nc. was founded in 2006 and is headquartered in Schaumburg, Illinois.
Advisors' Opinion:- [By John Seward]
Among the changes announced Tuesday, Affiliated Managers Group (NYSE AMG) will replace Forest Laboratories Inc. (NYSE: FRX) in the S&P 500 after the close of trading on Monday, June 30. LaSalle Hotel Properties (NYSE: LHO) will replace Affiliated Managers in the S&P MidCap 400 and Sagent Pharmaceuticals Inc. (NASDAQ: SGNT) will replace LaSalle in the S&P SmallCap 600.
- [By James Brumley]
In no particular order…
Sagent Pharmaceuticals (SGNT)Though Sagent Pharmaceuticals (SGNT) makes a few dozen generic drugs and has a similar number in the works, odds are good most investors couldn’t name a single one of them… and that’s a good thing for anyone on the hunt for cheap stocks from the pharma world.
source from Top Stocks For 2015:http://www.topstocksblog.com/hot-sliver-companies-to-own-for-2015-2.html
No comments:
Post a Comment